Data to establish the optimal standard regimen and predicting the response to docetaxel therapy

Data to establish the optimal standard regimen and predicting the response to docetaxel therapy

This paper contains data to establish the optimal standard regimen and predicting the response to docetaxel therapy (Moawad, 2014) [1]. Docetaxel has been in use for over a decade without demonstrating data indicates a predictable response in the treatment of cancer. Data of puzzling response to doc...

Full description

Bibliographic Details
Main Author: Emad Y. Moawad
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Data in Brief
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340915002279
id doaj-5967a1ebab074fcc83ed415eef708ad0
record_format Article
spelling doaj-5967a1ebab074fcc83ed415eef708ad02020-11-25T01:21:15ZengElsevierData in Brief2352-34092015-12-015C43944610.1016/j.dib.2015.09.033Data to establish the optimal standard regimen and predicting the response to docetaxel therapyEmad Y. MoawadThis paper contains data to establish the optimal standard regimen and predicting the response to docetaxel therapy (Moawad, 2014) [1]. Docetaxel has been in use for over a decade without demonstrating data indicates a predictable response in the treatment of cancer. Data of puzzling response to docetaxel therapy was due to its cell cycle specific effect. Although several administered schedules were investigated, the relative therapeutic advantage of high versus low doses has not been identified yet. Also the antitumor target of docetaxel has not yet been identified to optimize therapy by predicting the response of patients prior to therapy to provide a protection against treatment failure. In the present paper, we demonstrate the data used to optimize docetaxel therapy and investigate the possibility of predicting for the first time the antitumor target of docetaxel.http://www.sciencedirect.com/science/article/pii/S2352340915002279
collection DOAJ
language English
format Article
sources DOAJ
author Emad Y. Moawad
spellingShingle Emad Y. Moawad
Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
Data in Brief
author_facet Emad Y. Moawad
author_sort Emad Y. Moawad
title Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
title_short Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
title_full Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
title_fullStr Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
title_full_unstemmed Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
title_sort data to establish the optimal standard regimen and predicting the response to docetaxel therapy
publisher Elsevier
series Data in Brief
issn 2352-3409
publishDate 2015-12-01
description This paper contains data to establish the optimal standard regimen and predicting the response to docetaxel therapy (Moawad, 2014) [1]. Docetaxel has been in use for over a decade without demonstrating data indicates a predictable response in the treatment of cancer. Data of puzzling response to docetaxel therapy was due to its cell cycle specific effect. Although several administered schedules were investigated, the relative therapeutic advantage of high versus low doses has not been identified yet. Also the antitumor target of docetaxel has not yet been identified to optimize therapy by predicting the response of patients prior to therapy to provide a protection against treatment failure. In the present paper, we demonstrate the data used to optimize docetaxel therapy and investigate the possibility of predicting for the first time the antitumor target of docetaxel.
url http://www.sciencedirect.com/science/article/pii/S2352340915002279
work_keys_str_mv AT emadymoawad datatoestablishtheoptimalstandardregimenandpredictingtheresponsetodocetaxeltherapy
_version_ 1725131397072420864

Similar Items